Publication:
Copper pathology in vulnerable brain regions in Parkinson’s disease
Copper pathology in vulnerable brain regions in Parkinson’s disease
dc.contributor.author | Davies, Katherine M | en_US |
dc.contributor.author | Bohic, Sylvain | en_US |
dc.contributor.author | Carmona, Asunción | en_US |
dc.contributor.author | Ortega, Richard | en_US |
dc.contributor.author | Cottam, Veronica | en_US |
dc.contributor.author | Hare, Dominic J | en_US |
dc.contributor.author | Finberg, John PM | en_US |
dc.contributor.author | Reyes, Stephanie | en_US |
dc.contributor.author | Halliday, Glenda | en_US |
dc.contributor.author | Mercer, Julian FB | en_US |
dc.contributor.author | Double, Kay L | en_US |
dc.date.accessioned | 2021-11-25T12:29:08Z | |
dc.date.available | 2021-11-25T12:29:08Z | |
dc.date.issued | 2014 | en_US |
dc.description.abstract | Synchrotron-based X-ray fluorescence microscopy, immunofluorescence, and western blotting were used to investigate changes in copper (Cu) and Cu-associated pathways in the vulnerable SN and locus coeruleus (LC), and non-degenerating brain regions, in cases of Parkinson’s disease and appropriate healthy and disease controls. In PD and incidental Lewy body disease (ILBD), levels of Cu and Cu transporter protein 1 (Ctr1), were significantly reduced in surviving neurons in the SN and LC. Specific activity of the cuproprotein superoxide dismutase 1 (SOD1) was unchanged in the SN in PD but was enhanced in the parkinsonian anterior cingulate cortex (ACC), a region with α-synuclein pathology, normal Cu and limited cell loss. These data suggest that regions affected by α-synuclein pathology may display enhanced vulnerability and cell loss if Cu-dependent protective mechanisms are compromised. Further investigation of copper pathology in PD may identify novel targets for the development of protective therapies for this disorder. | en_US |
dc.identifier.issn | 0197-4580 | en_US |
dc.identifier.uri | http://hdl.handle.net/1959.4/53592 | |
dc.language | English | |
dc.language.iso | EN | en_US |
dc.rights | CC BY-NC-ND 3.0 | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/au/ | en_US |
dc.source | Legacy MARC | en_US |
dc.subject.other | human brain | en_US |
dc.subject.other | copper | en_US |
dc.subject.other | copper transporter 1 (Ctr1) | en_US |
dc.subject.other | Parkinson’s disease | en_US |
dc.subject.other | superoxide dismutase 1 (SOD1) | en_US |
dc.subject.other | substantia nigra | en_US |
dc.title | Copper pathology in vulnerable brain regions in Parkinson’s disease | en_US |
dc.type | Journal Article | en |
dcterms.accessRights | open access | |
dspace.entity.type | Publication | en_US |
unsw.accessRights.uri | https://purl.org/coar/access_right/c_abf2 | |
unsw.description.publisherStatement | NOTICE: this is the author’s version of a work that was accepted for publication in Neurobiology of Aging. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Neurobiology of Aging, Vol. 35, Issue 4, (2014) DOI 10.1016/j.neurobiolaging.2013.09.034 | en_US |
unsw.identifier.doiPublisher | http://dx.doi.org/10.1016/j.neurobiolaging.2013.09.034 | en_US |
unsw.relation.faculty | Medicine & Health | |
unsw.relation.ispartofissue | 4 | en_US |
unsw.relation.ispartofjournal | Neurobiology of Aging | en_US |
unsw.relation.ispartofpagefrompageto | 858-866 | en_US |
unsw.relation.ispartofvolume | 35 | en_US |
unsw.relation.originalPublicationAffiliation | Davies, Katherine M, Neuroscience Research Australia, Faculty of Medicine, UNSW | en_US |
unsw.relation.originalPublicationAffiliation | Bohic, Sylvain, Inserm, U836, team 6, Rayonnement Synchrotron et Recherche Médicales, Grenoble Institut des Neurosciences, Grenoble, F-38042, France, European Synchrotron Radiation Facility, ESRF, BP220, Grenoble, F-38043, France, Université Joseph Fourier 1, Grenoble Institut des Neurosciences, Grenoble, France | en_US |
unsw.relation.originalPublicationAffiliation | Carmona, Asunción, University of Bordeaux, CENBG, UMR 5797, F-33170 Gradignan, France, CNRS, IN2P3, CENBG, UMR 5797, F-33170 Gradignan, France | en_US |
unsw.relation.originalPublicationAffiliation | Ortega, Richard, University of Bordeaux, CENBG, UMR 5797, F-33170 Gradignan, France, CNRS, IN2P3, CENBG, UMR 5797, F-33170 Gradignan, France | en_US |
unsw.relation.originalPublicationAffiliation | Cottam, Veronica, NeuRA | en_US |
unsw.relation.originalPublicationAffiliation | Hare, Dominic J, Elemental Bio-imaging Facility, University of Technology Sydney, Australia, The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia | en_US |
unsw.relation.originalPublicationAffiliation | Finberg, John PM, Faculty of Medicine, Technion, Haifa, Israel | en_US |
unsw.relation.originalPublicationAffiliation | Reyes, Stephanie, Neuroscience Research Australia, Faculty of Medicine, UNSW | en_US |
unsw.relation.originalPublicationAffiliation | Halliday, Glenda, Neuroscience Research Australia, Faculty of Medicine, UNSW | en_US |
unsw.relation.originalPublicationAffiliation | Mercer, Julian FB, Centre for Cellular and Molecular Biology, Deakin University, Melbourne, Australia | en_US |
unsw.relation.originalPublicationAffiliation | Double, Kay L, Neuroscience Research Australia, Faculty of Medicine, UNSW | en_US |
unsw.relation.school | Neuroscience Research Australia | * |
unsw.subject.fieldofresearchcode | 110903 Central Nervous System | en_US |
Files
Original bundle
1 - 1 of 1